Genetic profiling and biomarkers in peripheral T-cell lymphomas: current role in the diagnostic work-up.

Peripheral T-cell lymphomas are a heterogeneous, and usually aggressive, group of mature T-cell neoplasms with overlapping clinical, morphologic and immunologic features. A large subset of these neoplasms remains unclassifiable with current diagnostic methods ("not otherwise specified"). Genetic profiling and other molecular tools have emerged as widely applied and transformative technologies for discerning the biology of lymphomas and other hematopoietic neoplasms. Although the application of these technologies to peripheral T-cell lymphomas has lagged behind B-cell lymphomas and other cancers, molecular profiling has provided novel prognostic and diagnostic markers as well as an opportunity to understand the biologic mechanisms involved in the pathogenesis of these neoplasms. Some biomarkers are more prevalent in specific T-cell lymphoma subsets and are being used currently in the diagnosis and/or risk stratification of patients with peripheral T-cell lymphomas. Other biomarkers, while promising, need to be validated in larger clinical studies. In this review, we present a summary of our current understanding of the molecular profiles of the major types of peripheral T-cell lymphoma. We particularly focus on the use of biomarkers, including those that can be detected by conventional immunohistochemical studies and those that contribute to the diagnosis, classification, or risk stratification of these neoplasms. © 2021. The Author(s), under exclusive licence to United States & Canadian Academy of Pathology.

Citation

Francisco Vega, Catalina Amador, Amy Chadburn, Eric D Hsi, Graham Slack, L Jeffrey Medeiros, Andrew L Feldman. Genetic profiling and biomarkers in peripheral T-cell lymphomas: current role in the diagnostic work-up. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2022 Mar;35(3):306-318

Mesh Tags

Substances

PMID: 34584212

search → result